Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > Trials have not started:
View:
Post by RReis09 on Dec 15, 2020 8:00am

Trials have not started:

I have called every location 1) they never received Bucillamine. From company for trials.2) they will call you back , they never Do 3) they don't know anything about Bucillamine Trials... Look at companies that do trials. Notice the difference on government Site. They give the name and contact. When you call revives locations they have to transfer you to next bish because mostly nobody knows or heard of Bucillamine trial
Comment by Chrisxd5 on Dec 15, 2020 8:22am
Ok I believe you I'll sel my 1.2mil shares
Comment by TheWolf22 on Dec 15, 2020 8:32am
https://revivethera.com/2020/12/binding-of-sars-cov-2-spike-protein-to-ace2-is-disabled-by-thiol-based-drugs-evidence-from-in-vitro-sars-cov-2-infection-studies/ lol try harder.
Comment by RiskyBiz928 on Dec 15, 2020 8:49am
So their lying to us? Article published yesterday on "thecannabisstock.com" states: Revive Therapeutics is about to have the first results of its largest study, the FDA Phase 3 Clinical Trial for Bucillamine in COVID-19. The company estimated that over 200 patients will have completed the Study for the interim analysis by the end of December 2020. Thoughts?
Comment by cool888 on Dec 15, 2020 8:54am
Poster IS the liar !
Comment by RiskyBiz928 on Dec 15, 2020 8:57am
Hey Coolio - that's what I thought. If these results pan out, the SP will go ballistic.
Comment by RReis09 on Dec 15, 2020 8:56am
Give them a call. And you will get the "message" loud and clear.....
Comment by RiskyBiz928 on Dec 15, 2020 9:00am
Maybe they just don't have time to deal with annoying calls from investors - "are we there yet, huh? Sre we there yet". Probably too busy conducting RESEARCH! 
Comment by cool888 on Dec 15, 2020 9:11am
Remember at the beginning sites info was available on Clinicaltrials.gov and some jokers like our friend here started calling, that's why those info not posted.
Comment by HydraulicDick on Dec 15, 2020 9:32am
RReise, sell your junk and be gone. No one is holding you here...Bish
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities